p.81 抽出テキスト

文献

1 Gillman MW. Primordial prevention of cardiovascular disease. Circu-

lation 2015; 131: 599-601. PMID: 25605661 2. 厚生労働省.令和2年(2020)人口動態統計(確定数)の概況. https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei20/index. html 3. Ueshima H, Sekikawa A, Miura K, et al. Cardiovascular disease and risk factors in Asia: A selected review. Circulation 2008; 118: 2702- 2709. PMID: 19106393 4. Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb 2007; 14: 278-286. PMID: 18174657 5. 厚生労働統計協会.国民衛生の動向2021/2022.厚生の指標 増刊2021; 68: 67-68. 6. Kitamura A, Sato S, Kiyama M, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: The Akita-Osaka study. J Am Coll Cardiol 2008; 52: 71-79. PMID: 18582638 7. Hata J, Ninomiya T, Hirakawa Y, et al. Secular trends in cardiovascular disease and its risk factors in Japanese: Half-century data from the Hisayama Study (1961-2009). Circulation 2013; 128: 1198-1205. PMID: 23902756 8. Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, 1990-2001. Am J Epidemiol 2008; 167: 1358-1364. PMID: 18381360 9. Cui Y, Hao K, Takahashi J, et al. Age-Specific Trends in the Incidence and In-Hospital Mortality of Acute Myocardial Infarction Over 30 Years in Japan Report From the Miyagi AMI Registry Study. Circ J 2017; 81: 520-528. PMID: 28154296 10. Wanezaki M, Watanabe T, Nishiyama S, et al. Trends in the incidences of acute myocardial infarction in coastal and inland areas in Japan: The Yamagata AMI Registry. J Cardiol 2016; 68: 117-124. PMID: 26416407 11. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008; 118: 2725-2729. PMID: 19106396 12. Hisamatsu T, Segawa H, Kadota A, et al. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res 2020; 43: 1344-1351. PMID: 32636526 13. 厚生労働省.国民健康・栄養調査.https://www.mhlw.go.jp/bunya/ kenkou/kenkou_eiyou_chousa.html 14. Mukai N, Hata J, Hirakawa Y, et al. Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988-2012: the Hisayama Study. Diabetol Int 2019; 10: 198-205. PMID: 31275786 15. Yokoyama H, Oishi M, Takamura H, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care 2016; 4: e000294. PMID: 27752329 16. 佐田みずき,岡村智教.わが国における血清コレステロール値および脂質異常症の時代的推移.日循予防誌 2018; 53: 220-226. 17. 健康・体力づくり事業財団.最新たばこ情報:成人喫煙率(JT全国喫煙者率調査).https://www.health-net.or.jp/tobacco/statistics/ jt.html 18. Jousilahti P, Laatikainen T, Peltonen M, et al. Primary prevention and risk factor reduction in coronary heart disease mortality among working aged men and women in eastern Finland over 40 years: population based observational study. BMJ 2016; 352: i721. PMID: 26932978 19. Blomstedt Y, Norberg M, Stenlund H, et al. Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in Västerbotten County, Sweden, during 1990- 2006. BMJ Open 2015; 5: e009651. PMID: 26685034 20. Record NB, Onion DK, Prior RE, et al. Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. JAMA 2015; 313: 147-155. PMID: 25585326 21. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42: 3227-3337. PMID: 34458905 22. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA

Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140: e596-e646. PMID: 30879355 23 Cooney MT, Dudina A, D’Agostino R, et al. Cardiovascular risk-esti-

mation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation 2010; 122: 300-310. PMID: 20644026 24. Allan GM, Garrison S, McCormack J. Comparison of cardiovascular disease risk calculators. Curr Opin Lipidol 2014; 25: 254-265. PMID: 24977979 25. Soureti A, Hurling R, Murray P, et al. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil 2010; 17: 519-523. PMID: 20195154 26. Lopez-Gonzalez AA, Aguilo A, Frontera M, et al. Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial. Eur J Prev Cardiol 2015; 22: 389-396. PMID: 24491403 27. European Society of Cardiology: ESC. Cardiovascular Risk Age Calculator Based on the European Society Of Cardiology Heart Score Mode. https://www.aub.edu.lb/fm/vmp/calc3/esc.html 28. American college of cardiology: ACC. ASCVD Risk Estimator Plus. https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/ 29. Honda T, Chen S, Hata J, et al. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study. J Atheroscler Thromb 2022; 29: 345-361. PMID: 33487620 30. Nakai M, Watanabe M, Kokubo Y, et al. Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan. J Atheroscler Thromb 2020; 27: 1160-1175. PMID: 32023562 31. Harada A, Ueshima H, Kinoshita Y, et al. Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study. Hypertens Res 2019; 42: 567- 579. PMID: 30760890 32. Li Y, Yatsuya H, Tanaka S, et al. Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN. J Atheroscler Thromb 2021; 28: 816-825. PMID: 33041313 33. Sugiyama D, Turin TC, Yeasmin F, et al. Hypercholesterolemia and Lifetime Risk of Coronary Heart Disease in the General Japanese Population: Results from the Suita Cohort Study. J Atheroscler Thromb 2020; 27: 60-70. PMID: 31217364 34. Turin TC, Okamura T, Afzal AR, et al. Impact of hypertension on the lifetime risk of coronary heart disease. Hypertens Res 2016; 39: 548- 551. PMID: 26960917 35. Turin TC, Okamura T, Afzal AR, et al. Hypertension and lifetime risk of stroke. J Hypertens 2016; 34: 116-122. PMID: 26556566 36. Satoh M, Ohkubo T, Asayama K, et al. Lifetime Risk of Stroke and Coronary Heart Disease Deaths According to Blood Pressure Level: EPOCH-JAPAN (Evidence for Cardiovascular Prevention From Observational Cohorts in Japan). Hypertension 2019; 73: 52-59. PMID: 30763510 37. Satoh M, Ohkubo T, Asayama K, et al. A Combination of Blood Pressure and Total Cholesterol Increases the Lifetime Risk of Coronary Heart Disease Mortality: EPOCH-JAPAN. J Atheroscler Thromb 2021; 28: 6-24. PMID: 32269207 38. Imai Y, Hirata T, Saitoh S, et al. Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study. Hypertens Res 2020; 43: 1437-1444. PMID: 32620896 39. 日本動脈硬化学会.動脈硬化性疾患予防ガイドライン2022年版.日本動脈硬化学会 2022. 40. 日本動脈硬化学会.動脈硬化性疾患発症予測ツール(医師・医療従事者向け).https://www.j-athero.org/jp/general/ge_tool2/ 41. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 2019; 42: 1235-1481. PMID: 31375757 42. Sawano M, Kohsaka S, Okamura T, et al. National Integrated Project for Prospective Observation of Non-Communicable Disease and its Trends in the Aged (NIPPON DATA 80) Research Group. Validation of the european SCORE risk chart in the healthy middle-aged Japanese. Atherosclerosis 2016; 252: 116-121. PMID: 27521900 43. Nishimura K, Okamura T, Watanabe M, et al. Predicting coronary

heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham Risk Score: The Suita